A unifying multiple sclerosis etiology linking virus infection, sunlight, and vitamin D, through viral interleukin-10

Author(s): Hayes CE, Donald Acheson E

Abstract

Multiple sclerosis (MS) is a neurodegenerative disease of uncertain etiology. In MS, neurodegeneration is thought to be secondary to autoimmune-mediated damage. However, no cohesive explanation yet exists as to how environmental factors interact to induce a neurodegenerative autoimmune response. Insufficient sunlight exposure and chronic viral infections have been proposed as unrelated environmental risk factors for MS. We suggest that these risk factors may act synergistically to enable the pathogenic autoimmune response. Low ultraviolet light (UVL) exposure depletes vitamin D3 stores, and low vitamin D3 levels correlate strongly with high MS risk. The central nervous system converts vitamin D3 into 1,25-dihydroxyvitamin D3 (1,25-(OH)2 D3), a biologically active hormone with anti-inflammatory and neuro-protective functions that depend on IL-10-producing regulatory lymphocytes. Herpesvirus infection also correlates with MS risk. Some herpesviruses like Epstein-Barr virus produce an IL-10-like cytokine termed vIL-10. We hypothesize that vIL-10 may induce a dysfunction of IL-10-producing regulatory lymphocytes, thereby undermining the protective functions of sunlight, vitamin D3, and 1,25-(OH)2 D3. The vIL-10 could elicit a host immune response capable of neutralizing or depleting IL-10, or the vIL-10 could compete with IL-10 but fail to perform an essential IL-10 function. In either case, the lack of sunlight exposure and the herpes virus infection might synergize to induce a defect in IL-10-producing regulatory lymphocyte function that undermines self-tolerance mechanisms and enables a pathogenic autoimmune response to neural proteins.

Similar Articles

Exposure to environmental tobacco smoke is associated with increased risk for multiple sclerosis

Author(s): Hedström AK, Bäärnhielm M, Olsson T, Alfredsson L

Epstein-Barr virus in pediatric multiple sclerosis

Author(s): Alotaibi S, Kennedy J, Tellier R, Stephens D, Banwell B

Vitamin D and latitude as environmental factors in multiple sclerosis

Author(s): Niino M, Miyazaki Y, Fukazawa T, Kikuchi S

Differential twin concordance for multiple sclerosis by latitude of birthplace

Author(s): Islam T, Gauderman WJ, Cozen W, Hamilton AS, Burnett ME, et al.

The genetics of multiple sclerosis: An up-to-date review

Author(s): Gourraud PA, Harbo HF, Hauser SL, Baranzini SE

Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis

Author(s): Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A

Melanocortin 1 receptor genotype, past environmental sun exposure, and risk of multiple sclerosis

Author(s): Dwyer T, van der Mei I, Ponsonby AL, Taylor BV, Stankovich J, et al.

Prevalence of multiple sclerosis in Isfahan, Iran

Author(s): Etemadifar M, Janghorbani M, Shaygannejad V, Ashtari F

Incidence and prevalence of multiple sclerosis in southeastern Iran

Author(s): Moghtaderi A, Rakhshanizadeh F, Shahraki-Ibrahimi S

Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time

Author(s): Sahraian MA, Khorramnia S, Ebrahim MM, Moinfar Z, Lotfi J, et al.

Prevalence of multiple sclerosis in Isfahan, Iran

Author(s): Etemadifar M, Janghorbani M, Shaygannejad V, Ashtari F

Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria

Author(s): Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, et al.

Estimation of the dietary requirement for vitamin D in healthy adults

Author(s): Cashman KD, Hill TR, Lucey AJ, Taylor N, Seamans KM, et al.

Nutritional status and anthropometric measurements of patients with multiple sclerosis

Author(s): Saka M, Saka M, Koseler E, Metin S, Bilen S, et al.

Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis

Author(s): Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R

Evidence for genetic regulation of vitamin D status in twins with multiple sclerosis

Author(s): Orton SM, Morris AP, Herrera BM, Ramagopalan SV, Lincoln MR, et al.

Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis

Author(s): Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R

Vitamin D levels in people with multiple sclerosis and community controls in Tasmania, Australia

Author(s): van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Taylor BV, et al.

Dietary intake of vitamin D during adolescence and risk of multiple sclerosis

Author(s): Munger KL, Chitnis T, Frazier AL, Giovannucci E, Spiegelman D, et al.

Past exposure to sun, skin phenotype, and risk of multiple sclerosis: Case-control study

Author(s): van der Mei IA, Ponsonby AL, Dwyer T, Blizzard L, Simmons R, et al.